The treatment period is 12 weeks, however, they will be actively recruiting an estimated 200 patients throughout 2Q2016 - 1Q2018 with results coming out 3Q2018 as indicated on slide 9. I'd imagine it'd be pretty difficult to monitor all 200 patients at once. Furthermore, phase III is most likely to commence in 2019 (if successful) and finish just in time to accommodate the "trillion dollar" market.
- Forums
- ASX - By Stock
- ACW
- Ann: Xanamem & AIBL to showcase Cortisol Hypothesis in Alzheimers-ACW.AX
Ann: Xanamem & AIBL to showcase Cortisol Hypothesis in Alzheimers-ACW.AX, page-16
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.57M |
Open | High | Low | Value | Volume |
2.6¢ | 2.7¢ | 2.5¢ | $59.07K | 2.276M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2152913 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 6707443 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2152913 | 0.026 |
26 | 4904265 | 0.025 |
27 | 6742760 | 0.024 |
23 | 5699493 | 0.023 |
15 | 8136010 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 6707443 | 10 |
0.028 | 1041941 | 5 |
0.029 | 1522413 | 3 |
0.030 | 2603911 | 6 |
0.031 | 939453 | 4 |
Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |